A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- lin shen
Peking University Cancer Hospital & Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anhui Cancer Hospital
Hefei, Anhui, China
Recruiting - Anhui Provincial Hospital
Hefei, Anhui, China
Recruiting - Beijing Cancer Hospital
Beijing, Beijing Municipality, China
Recruiting - Beijing Gobroad Hospital
Beijing, Beijing Municipality, China
Recruiting - Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China
Recruiting - Fujian Cancer Hospital
Fuzhou, Fujian, China
Recruiting - Sun Yat-Sen University Cancer Center (sysucc)
Guangzhou, Guangdong, China
Recruiting - the First Affiliated Hospital of Guangdong Pharmaceutical University
Guangzhou, Guangdong, China
Recruiting - Guangxi Medical University Cancer Hospital
Nanning, Guangxi, China
Recruiting - Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China
Recruiting - the First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Recruiting - Henan Cancer Hospital
Zhengzhou, Henan, China
Recruiting - Hubei Cancer Hospital
Wuhan, Hubei, China
Recruiting - Xiangyang Central Hospital
Xiangyang, Hubei, China
Recruiting - the First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Recruiting - Liaoning Cancer Hospital
Shenyang, Liaoning, China
Recruiting - Qilu Hospital of Shandong University
Jinan, Shandong, China
Recruiting - Shandong Cancer Hospital
Jinan, Shandong, China
Recruiting - Fudan University Shanghai Cancer Center
Shanghai, Shanghai Municipality, China
Recruiting - Shanxi Cancer Hospital
Taiyuan, Shanxi, China
Recruiting - West China Hospital of Sichuan University
Chengdu, Sichuan, China
Recruiting - Sir Run Run Shaw Hospital，zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Recruiting - the First Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Recruiting - the Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Recruiting - Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Dec 2023
- Primary completion
- 28 Dec 2026
- Completion
- 28 Mar 2027
- Last update posted
- 12 Mar 2026
- Registered enrollment
- 178
- Registry id
- NCT06157827
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.